
Keywords: اسکلروز جانبی جانبی آمیوتروفی اسپورادیک; ALS; Amyotrophic lateral sclerosis; Bcl; 2 B-cell lymphoma-2; COX-2; cyclooxygenase-2; DHYZ; DihuangYinziFang; DPPH; 2,2-diphenyl-1-picrylhydrazyl; FALS; familial Amyotrophic lateral sclerosis; FasL; Fas ligand; FDA; Food and Drug Administration; IFN; Int